Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Synapse
CME: Emerging Therapeutic Targets for Schizophrenia: A Focus on Muscarinic Acetylcholine Receptor Activation
Medication in hand
Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms
Muscarinic Agonism
CME: Great Debates: Exploring Muscarinic Agonists in Schizophrenia Treatment
Brain receptors
Muscarinic Pathways in Schizophrenia: Unlocking New Therapeutic Targets
Neuron
CME: Meet Me at the Water Cooler: Schizophrenia
Patient and provider
CME: End of the Anticholinergic Era? Challenging Cases in Anticholinergic Deprescribing: Real-World Scenarios (Module 4)
Patient and provider
CME: End of the Anticholinergic Era? Deprescribing with Confidence: Strategies for Safe Medication Changes (Module 3)
Woman taking medication
CME: End of the Anticholinergic Era? Measuring the Impact: Understanding Anticholinergic Burden (Module 2)
Muscarinic Receptor
CME: I Love Muscarinic Control! Targeting the Muscarinic System in the Treatment of Schizophrenia
Medication
CME: End of the Anticholinergic Era? Breaking Down the Anticholinergic System: Risks and Realities (Module 1)

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page Next ›
  • Last page Last »
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy